Gastric cancer (GC) is one of the most common malignancies worldwide and has high morbidity and mortality rates. It is essential to elucidate the molecular events of GC proliferation and invasion, which will provide new therapeutic targets for GC. The inactivation of transforming growth factor-b receptor 2 (TGFbR2) correlates with cancer cell growth and metastasis, but the mechanisms underlying the downregulation of TGFbR2 expression remain unknown. MicroRNAs (miRNAs) act as post-transcriptional regulators and play a key role in the development of cancers. Bioinformatics analysis and luciferase reporter assays have shown that miR-155 directly binds to the 3 0 -UTR of TGFbR2 mRNA. In this study, we found that the TGFbR2 protein levels, but not mRNA levels, were downregulated in GC tissues, and the levels of miR-155
mechanisms underlying tumor metastasis. Analysis of the signaling pathways in GC cells provides novel biomarkers for valid molecular targeted therapy.
Transforming growth factor-b receptor 2 is involved in many biological processes, such as cell differentiation, cell growth, apoptosis, and cell migration. 5 Acting as a tumor suppressor, TGFbR2 participates in tumor growth and migration because of genetic mutation or promoter methylation, which has been reported in colorectal cancer, esophageal, and prostate cancers. [6] [7] [8] [9] Furthermore, TGFbR2 as a cancer inhibitor is downregulated in GC, which is associated with increased tumorigenicity. 10 Although the inactivation of TGFbR2 has been discovered in cancer, the molecular mechanisms connected with TGFbR2 in GC have not been investigated.
MicroRNAs are small non-coding RNAs of 19-25 nucleotides in length that post-transcriptionally regulate gene expression. [11] [12] [13] They play vital roles in regulating the translation and degradation of mRNAs by binding the 3 0 -UTRs of mRNAs. The biological functions of miRNAs that regulating gene expression include cell proliferation, cell apoptosis, stress tolerance, and fat metabolism. 14 Aberrant expression of miRNAs has been found in several cancers, which play novel roles as anti-oncogenes or oncogenes, depending on the function of the target genes. [15] [16] [17] Previous studies showed that aberrant expression of many miRNAs promote proliferation and metastases in GC. [18] [19] [20] However, the molecular events are not fully understood.
In the present study, we identified specific targeting sites for miR-155 in the 3 0 -UTR of the TGFbR2 gene by using bioinformatics prediction. Experimental confirmation studies then illustrated that the negative regulation TGFbR2 by miR-155 promoted the growth and invasion of GC.
Our findings indicate that miR-155, as a novel therapeutic target, provides a potential new treatment for GC.
| MATERIALS AND METHODS

| Patients and tissue samples
This study was approved by the Ethics Committee of Tianjin Medical University Cancer Institute and Hospital (Tianjin, China). All patients provided written informed consent to participate in the study. We obtained 5 pairs of human GC tissue and matched adjacent normal gastric tissues from GC patients who were undergoing gastrostomy at the Tianjin Medical University Cancer Institute and Hospital. None of the patients received antitumor therapy before surgery. All GC tissue and normal gastric tissues were confirmed histologically. The pathological type of GC was confirmed to be adenocarcinoma. Tissue fragments were frozen in liquid nitrogen immediately after surgical excision. Total protein and RNA from tissue samples were extracted and stored at À80°C.
| Animals
Male nude mice (BALB/c-nu, 6-8 weeks old) were purchased from the Model Animal Center of Nanjing University (Nanjing, China).
They were housed in a pathogen-free animal facility with access to water and food and allowed to eat and drink ad libitum. 
| Cell lines and cell cultures
The human gastric adenocarcinoma cell lines SGC7901 and MGC803
were obtained from the Shanghai Institute of Cell Biology, Chinese
Academy of Sciences (Shanghai, China). The cells were cultured in DMEM (Gibco, Carlsbad, CA, USA), supplemented with 10% FBS (Gibco) and 1% penicillin/streptomycin (Solarbio, Beijing, China). All of the cells were incubated in an atmosphere of 5% CO 2 at 37°C.
| Immunohistochemistry assay
Gastric cancer tissues and matched adjacent normal gastric tissues were fixed in 4% paraformaldehyde and embedded in paraffin. The tissues were sliced into 4-lm-thick sections. All slides were dewaxed twice with dimethylbenzene and rehydrated in a graded series of ethanol. Antigen retrieval was achieved by soaking the sections in 10 mmol/L citrate buffer (pH 6.0), then heating them to 220°C at high pressure for 3 minutes. To block endogenous peroxidase activity, the slides were soaked in 3% hydrogen peroxide for 20 minutes.
The tissue slides were treated with anti-human TGFbR2 mAb (1:50, sc-400; Santa Cruz Biotechnology, CA, USA), then incubated overnight in a humidified chamber at 4°C. On day 2, the slides were washed in PBS 3 times and secondary antibodies were added dropwise to slides for 40 minutes at 37°C. After washing again with PBS 3 times, sections were stained by diaminobenzidine and counterstained with hematoxylin. The sections were then dehydrated and coverslipped. Quantitative analysis was carried out by quantifying the fluorescence intensity from 6 sections.
| RNA extraction and RT-PCR
Total RNA was extracted from the cultured cells and tissues using and scrambled negative control RNA were transfected into each well.
The cells were harvested 24 or 48 hours after transfection for isolation of total RNA or at 48 hours for Western blot analysis.
| Protein isolation and Western blot analysis
The expression of TGFbR2 was assessed by Western blot analysis and GAPDH was used as an internal control. Total proteins were extracted from tissues and cultured cells that were solubilized in lysis buffer supplemented with a protease and phosphatase inhibitor cocktail on ice. Proteins were separated by 10% SDS-PAGE and then transferred to PVDF membranes (Roche, Mannheim, Germany). The membranes were incubated for 2 hour with 2% BSA at room temperature for 1 hour and incubated overnight at 4°C with primary anti-TGFbR2 (1:200; Santa Cruz Biotechnology) and anti-GAPDH
(1:5000; Santa Cruz Biotechnology). Subsequently, the membranes were washed and incubated with appropriate secondary antibodies.
The immune complexes were visualized with an ECL Prime Western
Blot Detection System (Thermo, EHVEGFACL, Carlsbad, CA, USA). 
|
| Identification of TGFbR2 as a potential downstream target of miR-155
The underlying molecular mechanisms of downregulation of TGFbR2 protein expression are largely unknown in GC. MicroRNAs play a significant role in post-transcriptional genes by cleaving specific mRNA or translational repression. We utilized 3 public bioinformatics tools to predict the theoretical potential target of miR-155 and the binding sites.
Then we found that miR-155 can potentially bind a region in the 3 0 -UTR of TGFbR2 mRNA ( Figure 1D) . Furthermore, the region that miR-155 directly targets is highly conserved, and the complementary basepairing reactions are shown in Figure 2A . One predicted hybridization is observed between miR-155 and the 3 0 -UTR of TGFbR2.
| Upregulation of miR-155 in GC tissues and validation of TGFbR2 as a direct target of miR-155
Low expression of TGFbR2 proteins were explored in GC tissues. In order to validate the actual relationship between miR-155 and TGFbR2 in GC, we further analyzed the levels of miR-155 in GC and NC tissues by real-time PCR. Compared with the adjacent non-cancerous tissues, a significant decrease of miR-520b/e was observed in GC tissues. As expected, miR-155 was clearly increased in GC tissues and decreased in the paired NC tissues ( Figure 1E ). Therefore, miR-155 is most likely the directly regulator of TGFbR2 in GC cells.
In order to investigate whether miR-155 could bind to the putative binding sites in the 3 0 -UTR of TGFbR2, we undertook a luciferase assay. As shown in Figure 2B 
| Effects of TGFbR2 overexpression and silencing in SGC7901 cells
The biological function of TGFbR2 was explored by overexpression or silencing of TGFbR2 using plasmid or siRNA, respectively. The siRNA sequence that targets human TGFbR2 cDNA was used to knock down the expression of TGFbR2, and the plasmid that expresses the ORF of TGFbR2 was designed to overexpress TGFbR2. As shown in Figure 4 , the expression levels of TGFbR2 3) . B, Quantitative analysis of (A) (n = 3). C, 5-Ethynyl-2-deoxyuridine (EdU) assays show that silencing of TGFbR2 promotes cell proliferation of GC cells, whereas overexpression of TGFbR2 inhibits cell proliferation (n = 3). D, Quantitative analysis of (C) (n = 3). E, Validation of TGFbR2-mediated cell migration by wound healing assay. pcDNA.NC, control plasmid; pcDNA TGFbR2, overexpression plasmid (n = 3). **P < .01 inflammation to immunological memory. Previous studies have illustrated that miR-155 played an oncogene role in GC, which is in accord with the present study. We also noticed that several miRNA profiling studies reported a downregulated alteration of miR-155 in GC. 28 The function of TGFbR2 in tumorigenesis is controversial. Previous research showed that TGFbR2 acted as a tumor inhibitor and was downregulated in cancer. 29 In this study, TGFbR2 also functioned as a tumor suppressor and its levels were decreased in GC tissue. However, the other research showed that TGFbR2 acted as a proto-oncogene; its expression was dramatically increased in non-small-cell lung cancer tissues compared with non-neoplastic tissues, and overexpression of TGFbR2 was a significant risk factor for decreased overall survival and disease-free survival in non-small-cell lung cancer patients. 30 The inconsistent expression of miR-155 and TGFbR2 might be explained by the differences in tumor classification, tumor staging, or immune functions. We should further address the biological functions of miR-155 and TGFbR2 in GC in future studies. These pathways indicated that one miRNA could target multiple genes, and 1 gene could also be regulated by more than 1 miRNA.
It was validated that
In conclusion, the present study showed that the upregulation of miR-155 promoted GC progression by suppressing the expression of 
